MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 49 filers reported holding MEREO BIOPHARMA GROUP PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,298 | -9.9% | 17,285 | -7.8% | 0.00% | – |
Q2 2023 | $24,745 | -61.6% | 18,746 | -79.4% | 0.00% | – |
Q1 2023 | $64,394 | -55.5% | 91,093 | -52.8% | 0.00% | – |
Q4 2022 | $144,722 | -3.5% | 192,962 | +11.0% | 0.00% | – |
Q3 2022 | $150,000 | +500.0% | 173,786 | +689.1% | 0.00% | – |
Q2 2022 | $25,000 | -84.3% | 22,024 | -53.4% | 0.00% | – |
Q1 2021 | $159,000 | +93.9% | 47,219 | +105.0% | 0.00% | – |
Q4 2020 | $82,000 | – | 23,038 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 2,048,757 | $6,904,000 | 2.75% |
Asymmetry Capital Management, L.P. | 1,063,264 | $3,583,000 | 1.85% |
Endurant Capital Management LP | 1,339,835 | $4,515,000 | 1.18% |
Altium Capital Management LP | 1,250,000 | $4,213,000 | 1.17% |
Affinity Asset Advisors, LLC | 900,000 | $3,033,000 | 1.03% |
DAFNA Capital Management LLC | 1,249,648 | $4,211,000 | 1.00% |
Boxer Capital, LLC | 6,226,673 | $20,984,000 | 0.71% |
Delphi Management Partners VIII, L.L.C. | 256,734 | $865,000 | 0.60% |
Rubric Capital Management LP | 2,914,861 | $9,823,000 | 0.57% |
Orbimed Advisors | 17,264,763 | $58,183,000 | 0.54% |